RGLS

Regulus Therapeutics Inc. News Headlines

$19.96
*  
1.66
9.07%
Get RGLS Alerts
*Delayed - data as of Oct. 31, 2014  -  Find a broker to begin trading RGLS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    RGLS After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Pre-Market Most Active for Oct 29, 2014 : ARCP, FB, WBK, NOK, NVO, PBR, INVN, BABA, RGLS, TVIX, QQQ, ARMH
10/29/2014 8:39:57 AM - NASDAQ.com News


RGLS Prices Stock Offering At $17/Share
10/28/2014 9:49:00 PM - RTT News


Sector Update: Health Stocks Generally Flat Pre-Bell
10/28/2014 9:00:24 AM - MT Newswires


Sector Update: Health Care
10/28/2014 8:54:16 AM - MT Newswires


Regulus Therapeutics (RGLS) Soars: Stock Rises 6.6% - Tale of the Tape
10/28/2014 8:51:00 AM - Zacks.com


InsiderInsights.com Daily Round Up 10/24/14: AGCO, BDBD, SABA
10/27/2014 2:55:00 AM - Seeking Alpha


3 Momentum Stocks to Watch in Biotechnology for Continued Upside
10/23/2014 3:39:00 PM - TheStreet


Regulus Therapeutics' RG-101 Poses Liver Cancer Risk
10/23/2014 11:03:00 AM - Seeking Alpha


Why Regulus Therapeutics Inc. Stock More Than Doubled
10/22/2014 3:46:21 PM - Motley Fool


Regulus Therapeutics Inc. (RGLS) Has Vaulted To A New High On Study Results
10/22/2014 9:36:00 AM - RTT News


NASDAQ Biotechnology Top Performers (As Of Market Open September 11)
9/11/2014 8:27:38 AM - David Krein


Regulus Therapeutics To Present At Wedbush Conference; Webcast At 9:45 AM ET
8/13/2014 8:45:00 AM - RTT News


GMED Outlook Spooks Investors, CYTX Trials Placed On Hold, INCY Gets FDA Date
8/6/2014 12:02:00 AM - RTT News


Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential
8/4/2014 7:36:00 AM - Seeking Alpha


Alnylam And Benitec
7/25/2014 8:16:00 AM - Seeking Alpha


Sector Update: Health Care Stocks Mostly Lower; Regulus Therapeutics Wins Orphan Drug Designation for Prospective Kidney Disease Treatment
7/21/2014 2:34:13 PM - MT Newswires


Sector Update: Health Care
7/21/2014 2:06:38 PM - MT Newswires


Commit To Purchase Regulus Therapeutics At $10, Earn 27.1% Annualized Using Options
3/14/2014 11:45:45 AM - BNK Invest


Focus on Regulus' Pipeline - Analyst Blog
3/11/2014 7:00:01 PM - Zacks.com


Pipeline Progress at Regulus - Analyst Blog
2/20/2014 6:20:01 PM - Zacks.com


Regulus (RGLS) Jumps: Stock Rises 5.6% - Tale of the Tape
1/17/2014 10:46:01 AM - Zacks.com


Healthcare Stocks Climbing in Afternoon; Regulus Rises on Q3 Results, HPV Drug Prospects
11/14/2013 2:05:48 PM - MT Newswires


Sector Update: Healthcare
11/14/2013 2:03:11 PM - MT Newswires


Biopharma's Hot Stocks for this Week! - Earnings ESP
11/12/2013 1:05:20 PM - Zacks.com


Regulus Therapeutics Inc. Enters Oversold Territory - Tale of the Tape
10/23/2013 8:07:07 AM - Zacks.com